Skip to main content
Reckitt Benckiser Group PLC logo

Reckitt Benckiser Group PLC — Investor Relations & Filings

Ticker · RKT ISIN · GB00B24CGK77 LEI · 5493003JFSMOJG48V108 IL Manufacturing
Open in API
Filings indexed 1,841 across all filing types
Latest filing 2021-07-28 Director's Dealing
Country GB United Kingdom
Listing IL RKT

About Reckitt Benckiser Group PLC

https://www.reckitt.com/

Reckitt Benckiser Group PLC is a global manufacturer of consumer products in the health, hygiene, and nutrition sectors. The company's mission is to protect, heal, and nurture in the pursuit of a cleaner, healthier world. It operates a portfolio of trusted brands, many of which hold market-leading positions in their categories. Key brands include Lysol, Dettol, Durex, Mucinex, Nurofen, Strepsils, Gaviscon, Finish, and Vanish. Leveraging scientific expertise and consumer insights, the company develops and distributes products designed to improve the daily lives of consumers worldwide, with over 30 million of its products sold daily.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a formal notification titled 'DIRECTOR/PDMR SHAREHOLDING' and references regulatory requirements like 'DTR 3.1.2-A' and 'Market Abuse Regulation'. It details transactions (purchases of shares) made by persons discharging managerial responsibilities (CFO, Non-Executive Directors). This content directly corresponds to the definition of Director's Dealing, which is classified as 'DIRS'. The presence of the RNS Number and the footer referencing the London Stock Exchange confirms it is a regulatory disclosure.
2021-07-28 English
Half-Year Report
Interim / Quarterly Report Classification · 100% confidence The document is an official announcement from Reckitt Benckiser Group PLC regarding their H1 2021 financial results. It contains detailed financial tables (Net Revenue, Operating Profit, EPS), management commentary on performance, strategic updates, and guidance. It is not a full Annual Report (10-K) but rather an interim financial report. It provides substantive financial data and analysis for the first half of the year, fitting the definition of an Interim/Quarterly Report (IR). H1 2021
2021-07-27 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal notification identified by the 'RNS Number' and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange'. The content details the 'Voting Rights and Capital' as of a specific date (30 June 2021), providing the total number of issued shares and total voting rights. This type of mandatory disclosure regarding the total number of voting rights, which serves as the denominator for shareholder notification obligations under DTR 5.6.1, is a specific regulatory announcement. While it relates to voting rights, it is not the results of a vote (DVA) but rather the current capital structure relevant to voting. Since it is a general regulatory announcement distributed via RNS and doesn't fit perfectly into the other specific categories like DIV, SHA, or DVA, the most appropriate classification is the general regulatory filing category, RNS, as it is explicitly branded as an RNS release.
2021-07-01 English
Director Declaration
Board/Management Information Classification · 99% confidence The document is titled 'Director Declaration' and announces that the CEO, Laxman Narasimhan, has been appointed as a Non-Executive Director of another company (Verizon Communications Inc.). This notification is made in accordance with FCA Listing Rules 9.6.14, which governs director changes. This specific type of announcement, detailing personal share transactions or directorship changes of executives, aligns directly with the definition of 'Director's Dealing' (DIRS) or potentially Board/Management Information (MANG). However, the content is specifically about a director taking an external role, which is a common trigger for insider/director disclosure rules. Given the options, 'Director's Dealing' (DIRS) is the closest fit for reporting executive appointments/changes that impact their status, although 'MANG' is also plausible. Since the document explicitly reports a change in a director's external role, and it is a formal regulatory announcement distributed via RNS, I will check the definitions again. DIRS is defined as 'Report of personal share transactions by company directors and executives (insider trades)'. MANG is 'Announcement of changes in the company's board of directors or senior management.' The announcement is about an external appointment, which is a change in management/director status. However, many regulatory feeds group director appointment/resignation notices under a broader 'Director's Dealing' or 'Insider' category if it relates to their status. Given the explicit mention of a director's new role, MANG is a strong candidate. Let's re-evaluate the RNS context. RNS filings often cover director changes. Since this is a formal announcement of a change in a director's status (taking a new board seat), MANG (Board/Management Information) is the most precise fit for the *content* of the change, rather than DIRS which usually implies share transactions. Since this is a formal regulatory announcement distributed via RNS, and it is short, it could also be RNS, but MANG is more specific to the content. I will classify it as MANG.
2021-06-25 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is clearly identified by the header 'RNS Number : 8978C' and contains regulatory language such as 'NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM' and references to DTR 3.1.2-A and Market Abuse Regulation. The content details specific share transactions (Sale of shares, Exercise of share options) by an executive ('Aditya Sehgal', 'President Nutrition'). This precisely matches the definition of a Director's Dealing report. The presence of the RNS distribution boilerplate confirms it is a regulatory announcement, but the specific content points directly to 'Director's Dealing' (DIRS) over the general 'RNS' fallback.
2021-06-23 English
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document is identified by the RNS Number header and contains multiple sections detailing 'NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM'. It specifically lists acquisitions of shares by executives (Laxman Narasimhan, Aditya Sehgal, etc.) in the company. This content directly corresponds to the definition of Director's Dealing (insider trades by executives/directors). The filing code for this is DIRS.
2021-06-17 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.